Cargando…

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

Cytotoxic T cells play a key role in adaptive immunity by killing infected or cancerous cells. While the transcriptional control of CD8 T cell differentiation and effector function following T cell activation has been extensively studied, little is known about epigenetic regulation of these processe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tay, Rong En, Olawoyin, Olamide, Cejas, Paloma, Xie, Yingtian, Meyer, Clifford A., Ito, Yoshinaga, Weng, Qing Yu, Fisher, David E., Long, Henry W., Brown, Myles, Kim, Hye-Jung, Wucherpfennig, Kai W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336313/ https://www.ncbi.nlm.nih.gov/pubmed/32374402 http://dx.doi.org/10.1084/jem.20191453

Ejemplares similares

Correction: Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
por: Tay, Rong En, et al.
Publicado: (2020)

CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq Analysis
por: Qiu, Xintao, et al.
Publicado: (2021)

Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
por: Evans, Levi W., et al.
Publicado: (2018)

Epigenetics in Brain Tumors: HDACs Take Center Stage
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2016)

Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10
por: Jiang, Wanlin, et al.
Publicado: (2022)

Abstract 19: Presence Of Psychiatric Diagnosis Negatively Impacts Patient-Reported Outcomes And Decreases Likelihood Of Autologous Reconstruction
por: Mehta, Sumarth K., et al.
Publicado: (2020)

Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity
por: Ito, Yoshinaga, et al.
Publicado: (2018)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
por: Cejas, Paloma, et al.
Publicado: (2021)

Blood Reflux-Induced Epigenetic Factors HDACs and DNMTs Are Associated with the Development of Human Chronic Venous Disease
por: Chang, Shun-Fu, et al.
Publicado: (2022)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
por: Bougdour, Alexandre, et al.
Publicado: (2009)

HDAC mediated suppression of histone turnover promotes epigenetic stability of heterochromatin
por: Aygün, Ozan, et al.
Publicado: (2013)

An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine
por: Schmauss, C.
Publicado: (2015)

Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors
por: Consalvi, Silvia, et al.
Publicado: (2022)

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023)

Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells
por: Song, Yoojin, et al.
Publicado: (2020)

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn’s disease patients
por: Chervy, Mélissa, et al.
Publicado: (2022)

Phosphorus containing analogues of SAHA as inhibitors of HDACs
por: Pun, Michael D., et al.
Publicado: (2022)

Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
por: Cini, Elena, et al.
Publicado: (2018)

HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference
por: Bourgeois, Camille T., et al.
Publicado: (2017)

Nuclear mechanosensing controls MSC osteogenic potential through HDAC epigenetic remodeling
por: Killaars, Anouk R., et al.
Publicado: (2020)

X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition
por: Volpatti, Jonathan R., et al.
Publicado: (2022)

HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
por: Cuttini, Emma, et al.
Publicado: (2023)

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
por: Wilson, Andrew J, et al.
Publicado: (2012)

Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability
por: Chao, Min-Wu, et al.
Publicado: (2015)

Adverse Human Health Impacts in the Anthropocene
por: Olawoyin, Richard
Publicado: (2018)

Esophageal adenocarcinoma with metastasis to the prostatic urethra and bladder
por: Olawoyin, Olamide M., et al.
Publicado: (2023)

Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases
por: McConnell, Melanie J., et al.
Publicado: (2015)

Epigenetics of amphetamine-induced sensitization: HDAC5 expression and microRNA in neural remodeling
por: Liu, Philip K., et al.
Publicado: (2016)

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
por: Hull, Elizabeth E., et al.
Publicado: (2016)

Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
por: Mrakovcic, Maria, et al.
Publicado: (2018)

Increase in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia
por: Zhang, Zhang, et al.
Publicado: (2019)

Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia
por: Song, C, et al.
Publicado: (2016)

IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation
por: Cui, Jikai, et al.
Publicado: (2021)

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
por: Li, Yuxin, et al.
Publicado: (2020)

HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells
por: Hoyos, Clotilde, et al.
Publicado: (2022)

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability
por: Chao, Min-Wu, et al.
Publicado: (2020)

Multi-batch single-cell comparative atlas construction by deep learning disentanglement
por: Lynch, Allen W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kfkeglfbbf48ht6vldljc9e2pm